arrow_back Back to App

Easier Return of Unused Medications: New Rules for Take-Back Programs

This act simplifies the return of unused medications, especially opioids, through take-back programs. It allows for safer disposal of unneeded substances, reducing the risk of misuse. Citizens can expect more efficient and potentially more incentivized drug return programs.
Key points
Entities collecting drugs can open packages to identify contents, enabling incentive programs for those returning medications.
These entities gain the option to securely transport collected drugs to another destruction site, instead of destroying them on-site.
The changes aim to enhance public safety by limiting access to unused controlled substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6896
Sponsor: Rep. Foxx, Virginia [R-NC-5]
Process start date: 2022-03-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

RETURN Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6896.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-03-02.

What are the main provisions?

Key points include:

  • Entities collecting drugs can open packages to identify contents, enabling incentive programs for those returning medications.
  • These entities gain the option to securely transport collected drugs to another destruction site, instead of destroying them on-site.
  • The changes aim to enhance public safety by limiting access to unused controlled substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Foxx, Virginia [R-NC-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Security